Christopher Peetz Net Worth & Insider Trades

Christopher Peetz - President and CEO, Mirum Pharmaceuticals, Inc

As of May 12, 2022

What is Christopher Peetz's Net Worth?

The current estimated net worth of Mirum Pharmaceuticals, Inc's President and CEO, Christopher Peetz, is estimated to be about $120.36K . Christopher Peetz owns about 229,597 units of Mirum Pharmaceuticals, Inc common stock. In the last 3 years at Mirum Pharmaceuticals, Inc, Christopher Peetz has sold an estimated value of $70.71K worth.

What is Christopher Peetz's Past Insider Trading?

Christopher Peetz's largest purchase order was 7,000 units , worth over $100.8K on November 29, 2021. Christopher Peetz's largest sale order was 3,672 units , worth over $70.71K on October 1, 2021. In total, Christopher Peetz has made about 10 transactions over 3 years of their time at Mirum Pharmaceuticals, Inc. Christopher Peetz usually trades in January, with the busiest year in 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Christopher Peetz's Salary in 2020?

As President and CEO of Mirum Pharmaceuticals, Inc, Christopher Peetz has a total base salary of $511,818 . Christopher Peetz received compensation valued at about $3,003,978 in 2020 after becoming President and CEO. The vast majority of their compensation came in the form of a bonus of $265,952 , option awards of $2,218,755 , and other compensation of $7,453 .

What is Christopher Peetz's' Mailing Address?

  • Mailing address is C/o Tobira Therapeutics, Inc. 701 Gateway Boulevard, #200 South San Francisco CA 94080 CA

Mirum Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Christopher Peetz 2020 $511,818 $265,952 $2,218,755 $7,453 $3,003,978
Christopher Peetz 2019 $457,614 $286,100 $5,491,471 - $6,235,185
Peter Radovich 2020 $277,992 $111,197 $2,255,631 - $2,644,820
Ian Clements, Ph.D. 2020 $378,390 $151,356 $848,348 $11,400 $1,389,494
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1759425/000119312521116249/d352758ddef14a.htm

What are Mirum Pharmaceuticals, Inc's Past Insider Trades?

Mirum Pharmaceuticals, Inc's most recent insider trade came on June 8, 2022 by James Flynn, Deerfield Mgmt Hif Lp, Deerfield Mgmt Iv Lp, Deerfield Management Company LP Series C, Deerfield Private Design Fund Iv Lp and Deerfield Healthcare Innovations Fund Lp who sold 38,478 units worth $962.26K . In the last 3 years, insiders at Mirum Pharmaceuticals, Inc have sold an estimated value of $3.82M and bought an estimated value of $113.81M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Ian Clements, Chief Financial Officer,  Jonathan Edwin Tucker, Chief Medical Officer,  and Christopher Peetz, President and CEO .

Mirum Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1